These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 28529715)

  • 1. Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins.
    Finlay D; Teriete P; Vamos M; Cosford NDP; Vuori K
    F1000Res; 2017; 6():587. PubMed ID: 28529715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IAP-targeted therapies for cancer.
    LaCasse EC; Mahoney DJ; Cheung HH; Plenchette S; Baird S; Korneluk RG
    Oncogene; 2008 Oct; 27(48):6252-75. PubMed ID: 18931692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer.
    Nachmias B; Ashhab Y; Ben-Yehuda D
    Semin Cancer Biol; 2004 Aug; 14(4):231-43. PubMed ID: 15219616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Cell Death by IAPs and Their Antagonists.
    Vasudevan D; Ryoo HD
    Curr Top Dev Biol; 2015; 114():185-208. PubMed ID: 26431568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma.
    Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Edenfield HR; Glickman JN; Yeap BY; Sugarbaker DJ; Bueno R
    J Pathol; 2007 Mar; 211(4):447-54. PubMed ID: 17253596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitors of apoptosis (IAPs) as cancer targets.
    Hunter AM; LaCasse EC; Korneluk RG
    Apoptosis; 2007 Sep; 12(9):1543-68. PubMed ID: 17573556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitors of apoptosis (IAPs) and their emerging role in cancer.
    LaCasse EC; Baird S; Korneluk RG; MacKenzie AE
    Oncogene; 1998 Dec; 17(25):3247-59. PubMed ID: 9916987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor of apoptosis proteins as targets for anticancer therapy.
    Fulda S
    Expert Rev Anticancer Ther; 2007 Sep; 7(9):1255-64. PubMed ID: 17892425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of apoptotic proteins: new targets for anticancer therapy.
    Saleem M; Qadir MI; Perveen N; Ahmad B; Saleem U; Irshad T; Ahmad B
    Chem Biol Drug Des; 2013 Sep; 82(3):243-51. PubMed ID: 23790005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy.
    Yang L; Cao Z; Yan H; Wood WC
    Cancer Res; 2003 Oct; 63(20):6815-24. PubMed ID: 14583479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoprotective effects of IAPs revealed by a small molecule antagonist.
    Galbán S; Hwang C; Rumble JM; Oetjen KA; Wright CW; Boudreault A; Durkin J; Gillard JW; Jaquith JB; Morris SJ; Duckett CS
    Biochem J; 2009 Feb; 417(3):765-71. PubMed ID: 18851715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitor of apoptosis proteins (IAPs) as regulatory factors of hepatic apoptosis.
    Wang K; Lin B
    Cell Signal; 2013 Oct; 25(10):1970-80. PubMed ID: 23770286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonists of IAP proteins as cancer therapeutics.
    Dynek JN; Vucic D
    Cancer Lett; 2013 May; 332(2):206-14. PubMed ID: 20685035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor of apoptosis proteins as intracellular signaling intermediates.
    Kocab AJ; Duckett CS
    FEBS J; 2016 Jan; 283(2):221-31. PubMed ID: 26462035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells.
    Bockbrader KM; Tan M; Sun Y
    Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1).
    Blankenship JW; Varfolomeev E; Goncharov T; Fedorova AV; Kirkpatrick DS; Izrael-Tomasevic A; Phu L; Arnott D; Aghajan M; Zobel K; Bazan JF; Fairbrother WJ; Deshayes K; Vucic D
    Biochem J; 2009 Jan; 417(1):149-60. PubMed ID: 18939944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy.
    Tomek M; Akiyama T; Dass CR
    J Pharm Pharmacol; 2012 Dec; 64(12):1695-702. PubMed ID: 23146031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.
    Varfolomeev E; Blankenship JW; Wayson SM; Fedorova AV; Kayagaki N; Garg P; Zobel K; Dynek JN; Elliott LO; Wallweber HJ; Flygare JA; Fairbrother WJ; Deshayes K; Dixit VM; Vucic D
    Cell; 2007 Nov; 131(4):669-81. PubMed ID: 18022362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone inhibits TNF-alpha-induced apoptosis and IAP protein downregulation in MCF-7 cells.
    Messmer UK; Pereda-Fernandez C; Manderscheid M; Pfeilschifter J
    Br J Pharmacol; 2001 Jun; 133(4):467-76. PubMed ID: 11399663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Bcl-2 or IAP proteins does not provoke mutations in surviving cells.
    Shekhar TM; Green MM; Rayner DM; Miles MA; Cutts SM; Hawkins CJ
    Mutat Res; 2015 Jul; 777():23-32. PubMed ID: 25916945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.